NCT04419493View on ClinicalTrials.gov

A Study in Healthy Men to Compare 2 Different Formulations of Alteplase

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 23, 2020

Primary Completion Date

June 21, 2021

Study Completion Date

June 21, 2021

Conditions
Healthy
Interventions
DRUG

Alteplase (from modified manufacturing process)

Alteplase, TPA-05

DRUG

Alteplase (from current manufacturing process)

Alteplase, TPA-02

DRUG

Heparin-Natrium-5000-ratiopharm (unfractionated heparin)

Heparin-Natrium-5000-ratiopharm (unfractionated heparin)

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04419493 - A Study in Healthy Men to Compare 2 Different Formulations of Alteplase | Biotech Hunter | Biotech Hunter